pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
chondrial-therapeutics PRESS RELEASE ARCHIVE
May 29, 2020
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
Dec 18, 2019
Chondrial Therapeutics Announces Dosing of First Patients in Phase 1 Clinical Program of CTI-1601 for Treatment of Friedreich’s Ataxia
Dec 18, 2019
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
Feb 6, 2017
Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia